热门资讯> 正文
2025-11-04 05:49
Vertex Pharmaceuticals (NASDAQ: VRTX) raises FY2025 sales outlook from $11.850 billion-$12.000 billion to $11.900 billion-$12.000 billion vs $11.987 billion estimate.